Tidal Vision, a biotechnology company focused on chitosan-based chemistries, announced the closure of a $140 million Series B financing round. The round was oversubscribed, exceeding its original target.
Demand came from strategically aligned investors, including Cambridge Companies SPG, Eni Next, Milliken & Company, KIRKBI Climate, and the Oman Investment Authority’s IDO Investments, among others.
The financing will enhance Tidal Vision’s performance and production capacity for chitosan-based solutions. Funds will also support expanded research and development efforts.
Tidal Vision is establishing new facilities in Europe, Texas, and Ohio to increase its operational footprint. These expansions will improve access to chitosan-based products for customers worldwide.
Craig Kasberg, CEO of Tidal Vision, expressed excitement about partnering with aligned investors. He noted that the company aims to better serve critical industries in clean water, agriculture, and materials.
Filipp Chebotarev, Managing Partner at Cambridge Companies SPG, highlighted Tidal Vision’s leadership in chitosan extraction and its commercial applications. He emphasized that these investments will enable the company to leverage its scientific breakthroughs across multiple sectors.
Tidal Vision aims to create scalable biomolecular solutions that positively impact critical industries, such as water treatment and agriculture. The company is committed to fostering a systemic environmental impact.
